Single-Port Robot assisted partial cystectomy for urachal adenocarcinoma

ABSTRACT

Objective:

We present a novel technique to perform single-port (SP) robot-assisted partial cystectomy with excision of the urachal remnant and bilateral pelvic lymph node dissection for urachal adenocarcinoma (¹–⁷).

Materials and Methods:

A 41-year-old male presented to the clinic for multiple episodes of hematuria and mucousuria. Office cystoscopy revealed a small solitary tumor at the dome of the bladder, with a diagnostic bladder biopsy revealing a tubule-villous bladder adenoma. Cross-sectional imaging of the chest/abdomen/pelvis revealed a 4.5 cm cystic mass arising from the urachus without evidence of local invasion and metastatic spread. He underwent SP robotic-assisted partial cystectomy with excision of the urachal remnant and bilateral pelvic lymph node dissection. Surgical steps include: 1) peritoneal incision to release the urachus and drop bladder 2) identification of urachal tumor 3) intraoperative live cystoscopic identification of bladder mass and scoring of tumor margins using Toggle Pro feature 4) tumor excision with partial cystectomy 5) cystorrhaphy 6) bilateral pelvic lymph node dissection 7) peritoneal interposition flap to mitigate lymphocele formation.

Results:

Surgery was successful, with no intraoperative complications, an operative time of 100 minutes, and estimated blood loss of 20 mL. The patient was discharged on post-op day one, and the Foley catheter removed one week after surgery. Final pathology revealed a 7.5 cm infiltrating urachal muscle-invasive adenocarcinoma of the bladder (pT2b). Negative surgical margins were achieved.

Conclusions:

Single-port robot-assisted partial cystectomy for urachal adenocarcinoma is safe and can achieve equivalent oncologic outcomes to the standard of care with minimally invasive and open techniques.

Available at: http://www.intbrazjurol.com.br/video-section/20240379_Sobhani_et_al

Int Braz J Urol. 2024; 50 (Video #10): 659-60

REFERENCES

• ¹
  Dursun F, Lim K, Svatek RS, Xu J, El-Zaatari ZM, Wenker EP, et al. Clinical outcomes and patterns of population-based management of urachal carcinoma of the bladder: An analysis of the National Cancer Database. Cancer Med. 2022;11:4273-82. doi: 10.1002/cam4.4786.
  » https://doi.org/10.1002/cam4.4786
• ²
  Li S, Meng X, Liang P, Feng C, Shen Y, Hu D, et al. Clinical and Radiological Features of Urachal Carcinoma and Infection. Front Oncol. 2021;11:702116. doi: 10.3389/fonc.2021.702116.
  » https://doi.org/10.3389/fonc.2021.702116
• ³
  Colombo JR Jr, Desai M, Canes D, Frota R, Haber GP, Moinzadeh A, et al. Laparoscopic partial cystectomy for urachal and bladder cancer. Clinics (Sao Paulo). 2008;63:731-4. doi: 10.1590/s1807-59322008000600004.
  » https://doi.org/10.1590/s1807-59322008000600004
• ⁴
  James K, Vasdev N, Mohan-S G, Lane T, Adshead JM. Robotic Partial Cystectomy for Primary Urachal Adenocarcinoma of the Urinary Bladder. Curr Urol. 2015;8:183-8. doi: 10.1159/000365714.
  » https://doi.org/10.1159/000365714
• ⁵
  Morgantini LA, Alzein A, Bharadwaj A, Del Pino MS, Egan E, Ganesh A, et al. A prospective study on single-port versus multiport patient-reported surgical outcomes. BJUI Compass. 2023;5:84-9. doi: 10.1002/bco2.290.
  » https://doi.org/10.1002/bco2.290
• ⁶
  Lv Z, Chen G, Li Y, Li J, Hu A, Yu X. Perioperative results of single-port vs multi-port robotic-assisted radical prostatectomy via peritoneal approach: a meta-analysis. J Robot Surg. 2023;17:1309-18. doi: 10.1007/s11701-023-01589-9.
  » https://doi.org/10.1007/s11701-023-01589-9
• ⁷
  Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol. 2017;71:96-108. doi: 10.1016/j.eururo.2016.06.010.
  » https://doi.org/10.1016/j.eururo.2016.06.010

Publication Dates

• Publication in this collection
  09 Sept 2024
• Date of issue
  Sep-Oct 2024

History

• Received
  01 July 2024
• Accepted
  05 July 2024
• Published
  25 July 2024